We have demonstrated earlier that the AR inhibitors prevent colon cancer growth and metastasis by inhibiting the NF-κB-mediated inflammatory signaling and VEGF-induced neo-vascularization27, 28, 30, 32. This evidence concerns the gene VEGFA and malignant colon neoplasm.